INTERNATIONAL NEUROMODULATION SOCI… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1995

Legal Domicile

Principal Officer

PHILLIPE RIGOARD

Phone

4156833237

Tax Period

2024-09-01 to 2025-08-31

INTERNATIONAL NEUROMODULATION SOCIETY, founded in 1995, is a small nonprofit in the Medical Research sector that reported $654K in total revenue in fiscal year 2024. Revenue fell 68% from the prior year — a significant decline worth monitoring. Expenses of $801K exceeded revenue, resulting in a 23% operating deficit.

Mission

TO CREATE A FORUM FOR CLINICIANS, BASIC SCIENTISTS & BIOENGINEERS INVOLVED WITH NEUROMODULATION THRU A COMBINATION OF SCIENTIFIC MEETINGS, WEBINARS, JOURNAL, PODCAST AND INTERACTIVE WEBSITE (COMPLETE STATEMENT ON SCHED O)

Program Service Accomplishments

Program 1

Expenses: $365,538

THE SOCIETY PRODUCES A PEER-REVIEWED, SCIENTIFIC JOURNAL, NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, WHICH IS INDEXED BY THE NATIONAL LIBRARY OF MEDICINE IN MEDLINE / PUBMED AND IS...

THE SOCIETY PRODUCES A PEER-REVIEWED, SCIENTIFIC JOURNAL, NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, WHICH IS INDEXED BY THE NATIONAL LIBRARY OF MEDICINE IN MEDLINE / PUBMED AND IS PUBLISHED EIGHT TIMES A YEAR. NEUROMODULATION IS THE PREEMINENT JOURNAL IN THE AREA OF NEUROMODULATION, PROVIDING OUR READERSHIP WITH THE STATE OF THE ART CLINICAL, TRANSLATIONAL AND BASIC SCIENCE RESEARCH IN OUR FIELD AND REPRESENTING THE NEEDS OF THE BROAD NEUROMODULATION COMMUNITY. (CONTINUES ON SCHEDULE O)

Program 2

Expenses: $103,047

OTHER INS PROGRAMS TO PROMOTE INTERDISCIPLINARY STUDIES AND FURTHER EDUCATIONAL EFFORTS IN THE FIELD OF NEUROMODULATION THROUGH SCIENTIFIC MEETINGS, PODCAST AND QUARTERLY NEWSLETTERS.

Program 3

Expenses: $92,389

INTERNATIONAL NEUROMODULATION SOCIETY ORGANIZES ITS WEBINARS, JOURNAL CLUBS, AND BIENNIAL WORLD CONGRESSES WITH THE AIM OF BRINGING TOGETHER AN INTERNATIONAL COMMUNITY OF PROFESSIONALS FROM MULTIPLE DISCIPLINES, WHO WOULD NOT OTHERWISE MEET, TO LEARN ABOUT THE BROAD SPECTRUM OF NEUROMODULATION SCIENCE AND THERAPIES. THE INS'S MISSION IS TO PROMOTE AND DISSEMINATE THE SCIENCE, EDUCATION, PRACTICE AND ACCESSIBILITY OF ALL ASPECTS OF NEUROMODULATION. THIS MULTIDISCIPLINARY SOCIETY BELIEVES THAT ALL SCIENTISTS, CLINICIANS, BIOENGINEERS, PROFESSIONS ALLIED TO MEDICINE, AND INDUSTRY PARTNERS WHO HAVE A SPECIALIST INTEREST IN NEUROMODULATION, CAN AND SHOULD WORK WITH THIS SOCIETY TO SHARE SCIENCE AND ENCOURAGE BEST PRACTICE FOR THE GOOD OF HUMANITY. (CONTINUES ON SCHEDULE O).

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $255,039

Program Service Revenue $316,313

Investment Income $35,143

Other Revenue $47,322

TOTAL REVENUE $653,817

Expense Breakdown

Grants Paid $30,758

Salaries & Benefits $576,696

Fundraising Expenses $0

Program Expenses $721,353

Other Expenses $194,002

TOTAL EXPENSES $801,456

Year-over-Year Comparison

	2024	2023	Change
Revenue	$653,817	$2,059,224	-0.7%
Expenses	$801,456	$2,491,959	-0.7%
Net Income	$-147,639	$-432,735	-0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$373,827

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KONSTANTIN SLAVIN	PRESIDENT	10.00	Officer Director	$0	$0	$0
MARC RUSSO	IMMED PAST-P	10.00	Officer Director	$0	$0	$0
ROBERT M LEVY	EDITOR-IN-CH	10.00	Officer	$221,900	$0	$221,900
JAN VESPER	PRESIDENT-EL	10.00	Officer Director	$0	$0	$0
LAWRENCE POREE	SECRETARY	10.00	Officer Director	$0	$0	$0
PHILLIPE RIGOARD	TREASURER	10.00	Director	$0	$0	$0
TIA SOFATZIS	EXECUTIVE DI	40.00	Officer	$151,927	$0	$151,927
ENRIQUE BRICHETTI	CHAPTER PRES	1.00	Director	$0	$0	$0
MICHELLE O'BRIEN	CHAPTER PRES	1.00	Director	$0	$0	$0
LISA GOUDMAN	CHAPTER PRES	1.00	Director	$0	$0	$0
HOUGELLE SIMPLICIO	CHAPTER PRES	1.00	Director	$0	$0	$0
ANUJ BHATIA	CHAPTER PRES	1.00	Director	$0	$0	$0
JIAN-GUO ZHANG	CHAPTER PRES	1.00	Director	$0	$0	$0
DIRK RASCHE	CHAPTER PRES	1.00	Director	$0	$0	$0
ANDREA LANDI	CHAPTER PRES	1.00	Director	$0	$0	$0
HIDEHIRO HIRABAYASHI	CHAPTER PRES	1.00	Director	$0	$0	$0
TAE-KYU LEE	CHAPTER PRES	1.00	Director	$0	$0	$0
AHMED RASLAN	CHAPTER PRES	1.00	Director	$0	$0	$0
EFSTATHIOS BOVIATIS	CHAPTER PRES	1.00	Director	$0	$0	$0
CARLOS TORNERO	CHAPTER PRES	1.00	Director	$0	$0	$0
MATTHIEU CACHEMAILLE	CHAPTER PRES	1.00	Director	$0	$0	$0
JAMES FITZGERALD	CHAPTER PRES	1.00	Director	$0	$0	$0
WITEK LIBIONKA	CHAPTER PRES	1.00	Director	$0	$0	$0
KLIMENT GATZINSKY	CHAPTER PRES	1.00	Director	$0	$0	$0
GUL TALU	CHAPTER PRES	1.00	Director	$0	$0	$0
DENYS FONTAINE	CHAPTER PRES	1.00	Director	$0	$0	$0
PARESH DOSHI	CHAPTER PRES	1.00	Director	$0	$0	$0
ALIF RAHMAN	CHAPTER PRES	1.00	Director	$0	$0	$0
RUTH GUR	CHAPTER PRES	1.00	Director	$0	$0	$0
CHINGIZ SHASHKIN	CHAPTER PRES	1.00	Director	$0	$0	$0
HANS CARMONA	CHAPTER PRES	1.00	Director	$0	$0	$0
MARIANO VEIGA	CHAPTER PRES	1.00	Director	$0	$0	$0
EMIL ISAGULYAN	CHAPTER PRES	1.00	Director	$0	$0	$0
KIRAN PATEL	DIRECTOR AT	1.00	Director	$0	$0	$0
CHRIS GILLIGAN	DIRECTOR AT	1.00	Director	$0	$0	$0
STANA BOJANIC	DIRECTOR AT	1.00	Director	$0	$0	$0
ASHISH GULVE	REGIONAL DIR	1.00	Director	$0	$0	$0
GUOMING LUAN	REGIONAL DIR	1.00	Director	$0	$0	$0
ARTHUR CUKIERT	REGIONAL DIR	1.00	Director	$0	$0	$0
PHILLIPE RIGOARD	DIRECTOR AT	1.00	Director	$0	$0	$0
DANIEL BENZECRY	REGIONAL DIR	1.00	Director	$0	$0	$0
STANA BOJANIC	REGIONAL DIR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$653,817	$801,456	$1,729,730	$-147,639
2024	$2,059,224	$2,491,959	$1,822,067	$-432,735
2023	$657,660	$720,066	$2,220,950	$-62,406
2022	$2,121,514	$2,360,159	$2,270,475	$-238,645
2022	$2,121,513	$2,360,158	$2,270,475	$-238,645
2021	$628,946	$538,530	$2,410,063	$90,416
2020	$340,273	$557,766	$2,337,464	$-217,493
2019	$2,048,945	$1,864,931	$2,516,906	$184,014
2018	$540,913	$569,701	$2,310,702	$-28,788
2018	$540,913	$569,701	$2,310,702	$-28,788

INTERNATIONAL NEUROMODULATION SOCIETY